🇪🇺 Pradaxa in European Union

EMA authorised Pradaxa on 18 March 2008

Marketing authorisation

EMA — authorised 18 March 2008

  • Marketing authorisation holder: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • Status: approved

Pradaxa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in European Union

Frequently asked questions

Is Pradaxa approved in European Union?

Yes. EMA authorised it on 18 March 2008.

Who is the marketing authorisation holder for Pradaxa in European Union?

BOEHRINGER INGELHEIM INTERNATIONAL GMBH holds the EU marketing authorisation.